Fibroblast	0	10	B-Gene_or_gene_product
growth	11	17	I-Gene_or_gene_product
factor	18	24	I-Gene_or_gene_product
receptor	25	33	I-Gene_or_gene_product
2	34	35	I-Gene_or_gene_product
-	35	36	O
positive	36	44	O
fibroblasts	45	56	O
provide	57	64	O
a	65	66	O
suitable	67	75	O
microenvironment	76	92	O
for	93	96	O
tumor	97	102	B-Pathological_formation
development	103	114	O
and	115	118	O
progression	119	130	O
in	131	133	O
esophageal	134	144	B-Pathological_formation
carcinoma	145	154	I-Pathological_formation
.	154	155	O

PURPOSE	157	164	O
:	164	165	O
Tumor	166	171	B-Cell
fibroblasts	172	183	I-Cell
(	184	185	O
TF	185	187	B-Cell
)	187	188	O
have	189	193	O
been	194	198	O
suggested	199	208	O
to	209	211	O
play	212	216	O
an	217	219	O
essential	220	229	O
role	230	234	O
in	235	237	O
the	238	241	O
complex	242	249	O
process	250	257	O
of	258	260	O
tumor	261	266	B-Pathological_formation
-	266	267	O
stroma	267	273	B-Tissue
interactions	274	286	O
and	287	290	O
tumorigenesis	291	304	O
.	304	305	O

The	306	309	O
aim	310	313	O
of	314	316	O
the	317	320	O
present	321	328	O
study	329	334	O
was	335	338	O
to	339	341	O
investigate	342	353	O
the	354	357	O
specific	358	366	O
role	367	371	O
of	372	374	O
TF	375	377	B-Cell
in	378	380	O
the	381	384	O
esophageal	385	395	B-Pathological_formation
cancer	396	402	I-Pathological_formation
microenvironment	403	419	O
.	419	420	O

EXPERIMENTAL	421	433	O
DESIGN	434	440	O
:	440	441	O
An	442	444	O
Affymetrix	445	455	O
expression	456	466	O
microarray	467	477	O
was	478	481	O
used	482	486	O
to	487	489	O
compare	490	497	O
gene	498	502	O
expression	503	513	O
profiles	514	522	O
between	523	530	O
six	531	534	O
pairs	535	540	O
of	541	543	O
TFs	544	547	B-Cell
and	548	551	O
normal	552	558	O
fibroblasts	559	570	B-Cell
from	571	575	O
esophageal	576	586	B-Pathological_formation
squamous	587	595	I-Pathological_formation
cell	596	600	I-Pathological_formation
carcinoma	601	610	I-Pathological_formation
(	611	612	O
ESCC	612	616	B-Pathological_formation
)	616	617	O
.	617	618	O

Differentially	619	633	O
expressed	634	643	O
genes	644	649	O
were	650	654	O
identified	655	665	O
,	665	666	O
and	667	670	O
a	671	672	O
subset	673	679	O
was	680	683	O
evaluated	684	693	O
by	694	696	O
quantitative	697	709	O
real	710	714	O
-	714	715	O
time	715	719	O
PCR	720	723	O
and	724	727	O
immunohistochemistry	728	748	O
.	748	749	O

RESULTS	750	757	O
:	757	758	O
About	759	764	O
43	765	767	O
%	767	768	O
(	769	770	O
126	770	773	O
of	774	776	O
292	777	780	O
)	780	781	O
of	782	784	O
known	785	790	O
deregulated	791	802	O
genes	803	808	O
in	809	811	O
TFs	812	815	B-Cell
were	816	820	O
associated	821	831	O
with	832	836	O
cell	837	841	B-Cell
proliferation	842	855	O
,	855	856	O
extracellular	857	870	B-Cellular_component
matrix	871	877	I-Cellular_component
remodeling	878	888	O
,	888	889	O
and	890	893	O
immune	894	900	O
response	901	909	O
.	909	910	O

Up	911	913	O
-	913	914	O
regulation	914	924	O
of	925	927	O
fibroblast	928	938	B-Gene_or_gene_product
growth	939	945	I-Gene_or_gene_product
factor	946	952	I-Gene_or_gene_product
receptor	953	961	I-Gene_or_gene_product
2	962	963	I-Gene_or_gene_product
(	964	965	O
FGFR2	965	970	B-Gene_or_gene_product
)	970	971	O
,	971	972	O
which	973	978	O
showed	979	985	O
the	986	989	O
most	990	994	O
significant	995	1006	O
change	1007	1013	O
,	1013	1014	O
was	1015	1018	O
detected	1019	1027	O
in	1028	1030	O
all	1031	1034	O
six	1035	1038	O
tested	1039	1045	O
TFs	1046	1049	B-Cell
compared	1050	1058	O
with	1059	1063	O
their	1064	1069	O
paired	1070	1076	O
normal	1077	1083	O
fibroblasts	1084	1095	B-Cell
.	1095	1096	O

A	1097	1098	O
further	1099	1106	O
study	1107	1112	O
found	1113	1118	O
that	1119	1123	O
FGFR2	1124	1129	B-Gene_or_gene_product
-	1129	1130	O
positive	1130	1138	O
fibroblasts	1139	1150	O
were	1151	1155	O
only	1156	1160	O
observed	1161	1169	O
inside	1170	1176	O
the	1177	1180	O
tumor	1181	1186	B-Tissue
tissues	1187	1194	I-Tissue
and	1195	1198	O
not	1199	1202	O
in	1203	1205	O
tumor	1206	1211	B-Tissue
-	1211	1212	I-Tissue
surrounding	1212	1223	I-Tissue
stromal	1224	1231	I-Tissue
tissues	1232	1239	I-Tissue
,	1239	1240	O
suggesting	1241	1251	O
that	1252	1256	O
FGFR2	1257	1262	B-Gene_or_gene_product
could	1263	1268	O
be	1269	1271	O
used	1272	1276	O
as	1277	1279	O
a	1280	1281	O
TF	1282	1284	B-Cell
-	1284	1285	O
specific	1285	1293	O
marker	1294	1300	O
in	1301	1303	O
ESCC	1304	1308	B-Pathological_formation
.	1308	1309	O

Moreover	1310	1318	O
,	1318	1319	O
the	1320	1323	O
conditioned	1324	1335	O
medium	1336	1342	O
from	1343	1347	O
TFs	1348	1351	B-Cell
was	1352	1355	O
found	1356	1361	O
to	1362	1364	O
be	1365	1367	O
able	1368	1372	O
to	1373	1375	O
promote	1376	1383	O
ESCC	1384	1388	B-Cell
tumor	1389	1394	I-Cell
cell	1395	1399	I-Cell
growth	1400	1406	O
,	1406	1407	O
migration	1408	1417	O
,	1417	1418	O
and	1419	1422	O
invasion	1423	1431	O
in	1432	1434	O
vitro	1435	1440	O
.	1440	1441	O

CONCLUSIONS	1442	1453	O
:	1453	1454	O
Our	1455	1458	O
study	1459	1464	O
provides	1465	1473	O
new	1474	1477	O
candidate	1478	1487	O
genes	1488	1493	O
for	1494	1497	O
the	1498	1501	O
esophageal	1502	1512	B-Pathological_formation
cancer	1513	1519	I-Pathological_formation
microenvironment	1520	1536	O
.	1536	1537	O

Based	1538	1543	O
on	1544	1546	O
our	1547	1550	O
results	1551	1558	O
,	1558	1559	O
we	1560	1562	O
hypothesize	1563	1574	O
that	1575	1579	O
FGFR2	1580	1585	B-Gene_or_gene_product
(	1585	1586	O
+	1586	1587	O
)	1587	1588	O
-	1588	1589	O
TFs	1589	1592	O
might	1593	1598	O
provide	1599	1606	O
cancer	1607	1613	B-Cell
cells	1614	1619	I-Cell
with	1620	1624	O
a	1625	1626	O
suitable	1627	1635	O
microenvironment	1636	1652	O
via	1653	1656	O
secretion	1657	1666	O
of	1667	1669	O
proteins	1670	1678	O
that	1679	1683	O
could	1684	1689	O
promote	1690	1697	O
cancer	1698	1704	O
development	1705	1716	O
and	1717	1720	O
progression	1721	1732	O
through	1733	1740	O
stimulation	1741	1752	O
of	1753	1755	O
cancer	1756	1762	B-Cell
cell	1763	1767	I-Cell
proliferation	1768	1781	O
,	1781	1782	O
induction	1783	1792	O
of	1793	1795	O
angiogenesis	1796	1808	O
,	1808	1809	O
inhibition	1810	1820	O
of	1821	1823	O
cell	1824	1828	B-Cell
adhesion	1829	1837	O
,	1837	1838	O
enhancement	1839	1850	O
of	1851	1853	O
cell	1854	1858	B-Cell
mobility	1859	1867	O
,	1867	1868	O
and	1869	1872	O
promotion	1873	1882	O
of	1883	1885	O
the	1886	1889	O
epithelial	1890	1900	B-Cell
-	1900	1901	O
mesenchymal	1901	1912	B-Cell
transition	1913	1923	O
.	1923	1924	O

